SEC Form 4 · accession 0001179110-15-007090
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 10:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | May 1, 2015 | M | 35,315 | $5.74 | A | 166,473 | D | |
| Common StockF2 | May 1, 2015 | S | 35,315 | $8.359 | D | 131,158 | D | |
| Common Stock | May 4, 2015 | M | 10,647 | $5.74 | A | 141,805 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.74 | May 1, 2015 | M | 35,315 | D | May 9, 2006 | May 9, 2015 | Common Stock | 35,315 | 11,862 | D |
| Stock Option (right to buy)F1 | $5.74 | May 4, 2015 | M | 10,647 | D | May 9, 2006 | May 9, 2015 | Common Stock | 10,647 | 1,215 | D |
Explanation of responses
- F1Exercisable as to 50,000 shares commencing on May 9, 2006, 50,000 shares commencing on May 9, 2007, 50,000 shares commencing on May 9, 2008 and 50,000 shares commencing on May 9, 2009.
- F2Weighted average price of shares sold.
- F3This transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 13, 2014.